Position in ANAB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$252,449
+$18,465 QoQ
Shares Held
3,740
-40.9% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#143
of 211 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $2,116,200,383 across 427 Biotechnology names. ANAB ranks #98 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,182,479 | $490,208,754 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
980,259 | $486,924,048 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
875,859 | $263,659,830 | |
| 4 | INCY |
Incyte Corp
|
1,132,050 | $128,329,182 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
174,515 | $108,817,078 | |
| 6 | MRNA |
Moderna, Inc.
|
944,457 | $66,140,319 | |
| 7 | INSM |
INSMED Inc
|
416,487 | $44,405,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
545,761 | $42,716,712 |
All Filings in ANAB
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $252,449 | 3,740 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $233,984 | 4,219 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $83,286 | 1,718 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,837 | 158 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $28,770 | 1,296 | Shares | Sole | 2025-11-21 | |
| 2025-03-31 | $25,059 | 1,348 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $16,178 | 1,222 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $137,077 | 4,092 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $51,823 | 2,068 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $21,144 | 939 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $153,794 | 7,180 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $47,467 | 2,643 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $30,284 | 1,489 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $24,848 | 1,142 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $70,965 | 2,290 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $23,748 | 931 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $16,259 | 801 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $689,130 | 27,855 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,392,293 | 40,066 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,023,074 | 37,724 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $979,558 | 37,777 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $20,127 | 934 | Shares | Defined | 2021-07-20 | |
| 2020-09-30 | $44 | 3 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,027 | 46 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,062 | 146 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||